Skip to main content
. 2016 Aug 16;1(1):e78–e89. doi: 10.5114/amsad.2016.61788

Table II.

Echocardiography parameters, medical and device therapy

Variable HF (n = 52) HFrEF (n = 33) HFpEF (n = 19) REF (n = 20) All (n = 72)
Echocardiographic parameters:
 LVEF [%], mean ± SD 42.0 ±14.8 31.6 ±7.2 58.2 ±5.3 61.4 ±4.7 43.7 ±15.2
 LAD [mm], mean ± SD 45.0 ±6.2 45.8 ±7.5 43.8 ±2.7 32.4 ±2.9 43.9 ±7.0
 LVEDD [mm], mean ± SD 57.7 ±10.0 60.0 ±9.1 52.0 ±9.0
 IVSDd [mm], mean ± SD 11.5 ±2.6 11.1 ±2.6 12.4 ±2.5
 Right-ventricular dilatation, n (%) 11 (21.2) 10 (30.3) 1 (5.3)
 E-wave [cm/s], mean ± SD 62.4 ±32.5 55.4 ±47.6 69.3 ±14.8
 DT [ms], mean ± SD 196.9 ±83.8 173.5 ±85.2 228.7 ±73.2
 IVRT [ms], mean ± SD 125.7 ±34.1 130.7 ±40.1 119.2 ±22.1
 E/E’ [cm/s], mean ± SD 13.9 ±8.8 15.5 ±10.5 11.4 ±4.9
 Diastolic dysfunction, n (%) 48 (92.3) 29 (87.9) 19 (100)
Medical therapy:
 β-Blocker, n (%) 43 (82.7) 30 (90.9) 13 (68.4)
 ACE inhibitor, n (%) 32 (61.5) 20 (60.6) 12 (63.2)
 Angiotensin receptor blocker, n (%) 20 (38.5) 13 (39.4) 7 (36.8)
 Thiazide diuretics, n (%) 17 (32.7) 8 (24.2) 9 (47.4)
 Loop diuretic, n (%) 28 (53.8) 23 (69.7) 5 (26.3)
 Mineralocorticoid receptor antagonist, n (%) 16 (30.8) 12 (36.4) 4 (21.1)
 Statin, n (%) 36 (69.2) 23 (69.7) 13 (68.4)
 ASA, n (%) 39 (75.0) 24 (72.7) 15 (78.9)
Device therapy:
 Pacemaker, n (%) 6 (11.5) 4 (12.1) 2 (10.5)
 ICD, n (%) 11 (21.2) 10 (30.3) 1 (5.3)
 CRT-(D), n (%) 15 (28.8) 11 (33.3) 4 (21.1)

LVEF – left ventricular ejection fraction, LAD – left atrial diameter, LVEDD – left ventricular end-diastolic diameter, IVSDd – interventricular septal diameter in diastole, E-wave – early-wave, DT – deceleration time, IVRT – isovolumic relaxation time, ACE – angiotensin converting enzyme, ASA – acetylsalicylic acid, ICD – internal cardioverter-defibrillator, CRT-(D) – cardiac resynchronization therapy (-defibrillator).